Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

Approved Drug Products containing MolPort-001-742-263 listed in the FDA Orange Book. Original Data : FDA Website

Client Email

Product

MolPort-001-742-263
FDA Orange Book

Renejix: CDMO with expertise in small molecule oral dosage, delivery tech, and multi-modality manufacturing.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Ribobay has expertise in oligonucleotides from siRNA, Antisense Oligonucleotides, miRNAs, and aptamers & Oligonucleotides CXOs.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

MolPort-001-742-263

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

12 API Suppliers, 7 USDMF, 9 NDC API, 6 Listed Suppliers, $ API Reference Price

12 API Suppliers
7 USDMF
9 NDC API
6 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports

API Reference Price
API Exports
API Imports
FDF Exports

FINISHED DOSAGE FORMULATIONS

30 FDF Dossiers, 1 FDA Orange Book, 19 Europe, 1 Canada, 9 Listed Dossiers

30 FDF Dossiers
1 FDA Orange Book
19 Europe
1 Canada
9 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 15 SPI Pharma, 2 Seqens, 13 DKSH, 2 Jai Radhe Sales, 2 Pharm-RX Chemical, 1 Boai NKY Pharmaceuticals Ltd, 9 Gangwal Healthcare, 21 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 4 ACG Worldwide, 12 Actylis, 4 Aeon Procare, 1 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 46 BASF, 1 Bioplus Life Sciences, 2 BioSpectra, 2 Clariant, 20 Corel Pharma Chem, 1 DFE Pharma, 3 Doshion Polyscience, 5 Finar, 17 Gangwal Chemicals, 6 Ideal Cures Pvt Ltd, 3 Ingredion Pharma Solutions, 19 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 8 Lubrizol Life Science Health, 12 Microlex e.U, 2 Nanjing Bold Chemical, 2 Nomisma Healthcare, 3 Novo Excipients, 1 Pharmatrans-Sanaq, 5 Pluviaendo, 1 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 18 Roquette, 27 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 4 Sigachi Industries, 3 The Dow Chemical Company, 1 TopChem Pharmaceuticals, 1 Ulanqab Kema New Material, 2 Valens Pharmachem, 1 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

82 Topical, 66 Solubilizers, 57 Coating Systems & Additives, 45 Thickeners and Stabilizers, 44 Fillers, Diluents & Binders, 36 Controlled & Modified Release, 32 Emulsifying Agents, 32 Parenteral, 30 Direct Compression, 26 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 20 Granulation, 18 Disintegrants & Superdisintegrants, 17 Taste Masking, 17 Co-Processed Excipients, 16 Lubricants & Glidants, 12 Rheology Modifiers, 10 API Stability Enhancers, 10 Chewable & Orodispersible Aids, 9 Empty Capsules, 4 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

82 Topical
66 Solubilizers
57 Coating Systems & Additives
45 Thickeners and Stabilizers
44 Fillers, Diluents & Binders
36 Controlled & Modified Release
32 Emulsifying Agents
32 Parenteral
30 Direct Compression
26 Film Formers & Plasticizers
20 Surfactant & Foaming Agents
20 Granulation
18 Disintegrants & Superdisintegrants
17 Taste Masking
17 Co-Processed Excipients
16 Lubricants & Glidants
12 Rheology Modifiers
10 API Stability Enhancers
10 Chewable & Orodispersible Aids
9 Empty Capsules
4 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

13 NEWS #PharmaBuzz

13 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 17 Finished Drug Prices, 2 Annual Reports

1 US Medicaid Prescriptions
17 Finished Drug Prices
2 Annual Reports

MARKET PLACE

14 APIs

14 APIs

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 USP, 1 Others

1 EDQM
2 USP
1 Others

ANALYTICAL

2 Analytical Methods

2 Analytical Methods

$ API Ref.Price (USD/KG) : 1,516 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

1 All

01 1AVERITAS

filter Dosage Reset all filters

1 All

01 1PATCH;TOPICAL

filter Regulatory Info Reset all filters

1 All

01 1RX

filter Brand Name Reset all filters

1 All

01 1QUTENZA

filter RLD Reset all filters

1 All

01 1Yes

FDF Dossiers
FDA Orange Book
Europe
Canada
Listed Dossiers

List of Suppliers

Product Main Page

01

AVERITAS

AAPS 2024

Not Confirmed

AVERITAS

AAPS 2024

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

RLD : Yes

TE Code :

Brand Name : QUTENZA

Dosage Form : PATCH;TOPICAL

Dosage Strength : 8%

Approval Date : 2009-11-16

Application Number : 22395

RX/OTC/DISCN : RX

RLD : Yes

TE Code :

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?